Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walt Disney
DIS
|
+$655M |
| 2 |
Coty
COTY
|
+$380M |
| 3 |
ConocoPhillips
COP
|
+$250M |
| 4 |
Zimmer Biomet
ZBH
|
+$213M |
| 5 |
Valero Energy
VLO
|
+$170M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$523M |
| 2 |
Merck
MRK
|
+$375M |
| 3 |
SHPG
Shire pic
SHPG
|
+$362M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$310M |
| 5 |
CELG
Celgene Corp
CELG
|
+$286M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 13.57% |
| 2 | Technology | 12.05% |
| 3 | Financials | 10.74% |
| 4 | Consumer Discretionary | 9.44% |
| 5 | Energy | 8.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1201
Spire
SR
$4.87B
| $10.4M | 0.02% |
+126,980
| New | +$9.9M |
|
1202
Unisys
UIS
$192M
| $10.4M | 0.02% |
894,339
-70,327
| -7% | -$907K |
|
1203
CALL
Bristol-Myers Squibb
BMY
$137B
| $10.4M | 0.02% |
218,700
+68,700
| +46% | +$3.42M |
|
1204
Compañía de Cervecerías Unidas
CCU
$2.34B
| $10.4M | 0.02% |
353,746
-4,672
| -1% | -$130K |
|
|
SNP
1205
DELISTED
CHINA PETROLEUM & CHEMICAL CORPORATION ADS (REP 100 ORDINARY H SHARES)
SNP
| $10.4M | 0.02% |
130,972
-21,586
| -14% | -$1.77M |
|
|
WMGI
1206
CALL
DELISTED
Wright Medical Group Inc
WMGI
| $10.4M | 0.02% |
+330,000
| New | +$10M |
|
|
AVNS
1207
DELISTED
Avanos Medical
AVNS
| $10.4M | 0.02% |
242,820
+158,673
| +189% | +$7.1M |
|
1208
Old Republic International
ORI
$10.1B
| $10.3M | 0.02% |
494,344
-96,739
| -16% | -$2.01M |
|
1209
Moelis & Co
MC
$5.07B
| $10.3M | 0.02% |
248,294
-169,457
| -41% | -$7.24M |
|
|
TMX
1210
DELISTED
Terminix Global Holdings, Inc.
TMX
| $10.3M | 0.02% |
221,147
-289,392
| -57% | -$12.1M |
|
1211
Shutterstock
SSTK
$198M
| $10.3M | 0.02% |
221,477
-29,783
| -12% | -$1.26M |
|
1212
McGrath RentCorp
MGRC
$2.85B
| $10.3M | 0.02% |
182,358
+13,071
| +8% | +$699K |
|
1213
iShares MSCI South Korea ETF
EWY
$27B
| $10.3M | 0.02% |
169,214
+97,514
| +136% | +$6.05M |
|
|
GG
1214
PUT
DELISTED
Goldcorp Inc
GG
| $10.3M | 0.02% |
+900,000
| New | +$9.67M |
|
1215
CALL
Penumbra
PEN
$12.8B
| $10.3M | 0.02% |
70,000
+62,500
| +833% | +$8.93M |
|
|
WBA
1216
CALL
DELISTED
Walgreens Boots Alliance
WBA
| $10.3M | 0.02% |
+162,100
| New | +$11.1M |
|
1217
Tanger
SKT
$4.47B
| $10.2M | 0.02% |
487,769
-929,077
| -66% | -$20M |
|
|
1218
PUT
Zimmer Biomet
ZBH
$19.3B
| $10.2M | 0.02% |
82,400
+72,100
| +700% | +$8.19M |
|
|
DOCU
1219
DocuSign
DOCU
$11.9B
| $10.2M | 0.02% |
196,963
+100,250
| +104% | +$5.12M |
|
|
TVPT
1220
DELISTED
Travelport Worldwide Limited
TVPT
| $10.2M | 0.02% |
648,251
+404,063
| +165% | +$6.34M |
|
1221
Coherus Oncology
CHRS
$210M
| $10.2M | 0.02% |
+746,362
| New | +$9.96M |
|
1222
Nokia
NOK
$55.6B
| $10.2M | 0.02% |
1,778,984
-7,860,039
| -82% | -$48.1M |
|
1223
Diodes
DIOD
$4.13B
| $10.2M | 0.02% |
293,215
+73,160
| +33% | +$2.62M |
|
|
PS
1224
DELISTED
Pluralsight, Inc. Class A Common Stock
PS
| $10.1M | 0.02% |
319,750
+161,425
| +102% | +$4.78M |
|
1225
PUT
Texas Instruments
TXN
$236B
| $10.1M | 0.02% |
95,500
+52,100
| +120% | +$5.4M |
|
Similar funds
Israel Englander's Q1 2019 Portfolio in Review
As of Q1 2019, Israel Englander held 4,608 positions worth $66.8B, up 4.2% from $64.1B the previous quarter. Its ten largest holdings account for 7.1% of the portfolio.
Israel Englander withdrew a net $6.14B in Q1 2019, closing 675 positions and reducing 1,467 holdings. Its most notable exit was Merck, an estimated $375M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 14% of assets, down from 14% a quarter earlier, followed by Technology and Financials.
Against the trend, Israel Englander opened a new position in Zimmer Biomet worth $232M.
- Israel Englander's largest Q1 2019 buy was Zimmer Biomet: 1,870,503 shares worth $232M.
- Israel Englander added most to Walt Disney in Q1 2019, an estimated $655M increase.
- Israel Englander's biggest Q1 2019 reduction was Apple, cutting an estimated $523M.
- Israel Englander fully exited Merck in Q1 2019, selling an estimated $375M.
- Israel Englander's ten largest holdings make up 7.1% of its $66.8B portfolio in Q1 2019.
- Israel Englander opened 914 new positions and closed 675 in Q1 2019.
- Israel Englander's portfolio value rose 4.2% quarter-over-quarter to $66.8B.
Based on Millennium Management's 13F filing for Q1 2019, filed 14 May 2019.